Lipoic acid suppression of neutrophil respiratory burst: Effect of NADPH

Antioxidants and Redox Signaling

Volumn 10, Issue 2, 2008, Pages 277-285

  O'Neill, Heidi C ^a   Rancourt, Raymond C ^b   White, Carl W ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOATE; DILUENT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; PHORBOL 13 ACETATE 12 MYRISTATE; PYRIDINE NUCLEOTIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MODEL; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG FLUID; NEUTROPHIL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REDUCTION; RESPIRATORY BURST; VOLUNTEER;

BACTERIAL INFECTIONS; FOLIC ACID; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; KINETICS; NADP; NEUTROPHILS; OXYGEN CONSUMPTION; PEROXIDASE; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; SUPEROXIDES; THIOCTIC ACID;

BACTERIA (MICROORGANISMS);

EID: 37549012137     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1890     Document Type: Article

References (59)

1. Ahmad S, White CW, Chang LY, Schneider BK, and Allen CB. Glutamine protects mitochondrial structure and function in oxygen toxicity. Am J Physiol Lung Cell Mol Physiol 280: L779-791, 2001.
2. Arner ES, Nordberg J, and Holmgren A. Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem Biophys Res Commun 225: 268-274, 1996.
3. Bast A and Haenen GR. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim Biophys Acta 963: 558-561, 1988.
4. Beck WS. The control of leukocyte glycolysis. J Biol Chem 232: 251-270, 1958.
5. Behr J, Maier K, Degenkolb B, Krombach F, and Vogelmeier C. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 156: 1897-1901, 1997.
6. Borok Z, Buhl R, Grimes GJ, Bokser AD, Hubbard RC, Holroyd KJ, Roum JH, Czerski DB, Cantin AM, and Crystal RG. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338: 215-216, 1991.
7. Bridgeman MM, Marsden M, Selby C, Morrison D, and MacNee W. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 49: 670-675, 1994.
8. Cantin AM, Hubbard RC, and Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139: 370-372, 1989.
9. Carre PC, Mortenson RL, King TE, Jr., Noble PW, Sable CL, and Riches DW. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest 88: 1802-1810, 1991.
10. Colotta F, Re F, Polentarutti N, Sozzani S, and Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80: 2012-2020, 1992.
11. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, and Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310: 235-244, 1984.
12. Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, and Hunninghake GW. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 70: 542-568, 1981.
13. Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, and du Bois RM. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 160: 899-905, 1999.
14. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez - Becerra E, Corvasce G, Lankhorst I, Sardina M, and Montanari M. Highdose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353: 2229-2242, 2005.
15. Fuchs J, Schofer H, Milbradt R, Freisleben HJ, Buhl R, Siems W, and Grune T. Studies on lipoate effects on blood redox state in human immunodeficiency virus infected patients. Arzneimittelforschung 43: 1359-1362, 1993.
16. Hagiwara SI, Ishii Y, and Kitamura S. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med 162: 225-231, 2000.
17. Handelman GJ, Han D, Tritschler H, and Packer L. Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium. Biochem Pharmacol 47: 1725-1730, 1994.
18. Haramaki N, Han D, Handelman GJ, Tritschler HJ, and Packer L. Cytosolic and mitochondrial systems for NADH- and NADPH-dependent reduction of alpha-lipoic acid. Free Radic Biol Med 22: 535-542, 1997.
19. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB, Jr., and Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119: 101-110, 1985.
20. Heyworth PG, Bohl BP, Bokoch GM, and Curnutte JT. Rac translocates independently of the neutrophil NADPH oxidase components p47phox and p67phox. Evidence for its interaction with flavocytochrome b558. J Biol Chem 269: 30749-30752, 1994.
21. Kagan VE, Shvedova A, Serbinova E, Khan S, Swanson C, Powell R, and Packer L. Dihydrolipoic acid - a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 44: 1637-1649, 1992.
22. Kinnula VL. Production and degradation of oxygen metabolites during inflammatory states in the human lung. Curr Drug Targets Inflamm Allergy 4: 465-470, 2005.
23. Kinnula VL, Soini Y, Kvist - Makela K, Savolainen ER, and Koistinen P. Antioxidant defense mechanisms in human neutrophils. Antioxid Redox Signal 4: 27-34, 2002.
24. Lenz AG, Costabel U, and Maier KL. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur Respir J 9: 307-312, 1996.
25. Li JM and Shah AM. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277: 19952-19960, 2002.
26. Lohr G and Waller H. Glucose-6-phosphate Dehydrogenase. In: Methods of Enzymatic Analysis. New York: Academic Press, 1974, p. 636-643.
27. Lynch JP, 3rd, Standiford TJ, Rolfe MW, Kunkel SL, and Strieter RM. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis 145: 1433-1439, 1992.
28. Maier K, Leuschel L, and Costabel U. Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 143: 271-274, 1991.
29. Marrades RM, Roca J, Barbera JA, de Jover L, MacNee W, and Rodriguez - Roisin R. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med 156: 425-430, 1997.
30. Mermigkis CM, Tsakanika K, Polychronopoulos V, Karagianidis N, Mermigkis D, and Bouros D. Expression of bcl-2 protein in bronchoalveolar lavage cell populations from patients with idiopathic pulmonary fibrosis. Acta Cytol 45: 914-918, 2001.
31. Meyer A, Buhl R, Kampf S, and Magnussen H. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 152: 1055-1060, 1995.
32. Meyer A, Buhl R, and Magnussen H. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 7: 431-436, 1994.
33. Moini H, Packer L, and Saris NE. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 182: 84-90, 2002.
34. Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, and Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 12: 1010-1019, 1998.
35. Nagy AM, Vanderbist F, Parij N, Maes P, Fondu P, and Neve J. Effect of the mucoactive drug nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils. Pulm Pharmacol Ther 10: 287-292, 1997.
36. Opitz N, Drummond GR, Selemidis S, Meurer S, and Schmidt HH. The 'A's and 'O's of NADPH oxidase regulation: a commentary on "Subcellular localization and function of alternatively spliced Noxo1 isoforms". Free Radic Biol Med 42: 175-179, 2007.
37. Packer L, Witt EH, and Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250, 1995.
38. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, and Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol 268: H2274-2280, 1995.
39. Pandolfi PP, Sonati F, Rivi R, Mason P, Grosveld F, and Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J 14: 5209-5215, 1995.
40. Park CS, Chung SW, Ki SY, Lim GI, Uh ST, Kim YH, Choi DI, Park JS, Lee DW, and Kitaichi M. Increased levels of interleukin-6 are associated with lymphocytosis in bronchoalveolar lavage fluids of idiopathic nonspecific interstitial pneumonia. Am J Respir Crit Care Med 162: 1162-1168, 2000.
41. Pohl WR, Schenk E, Umek H, Micksche M, Kummer F, and Kohn H. [Diagnostic value of secretory products of eosinophils and neutrophils in bronchoalveolar lavage in patients with idiopathic lung fibrosis]. Wien Klin Wochenschr 105: 387-392, 1993.
42. Prutz WA, Kissner R, Koppenol WH, and Ruegger H. On the irreversible destruction of reduced nicotinamide nucleotides by hypohalous acids. Arch Biochem Biophys 380: 181-191, 2000.
43. Rahman I and MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 28: 1405-1420, 2000.
44. Rahman I, Skwarska E, Henry M, Davis M, O'Connor CM, FitzGerald MX, Greening A, and MacNee W. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic Biol Med 27: 60-68, 1999.
45. Robinson J and Cooper JM. Method of determining oxygen concentrations in biological media, suitable for calibration of the oxygen electrode. Anal Biochem 33: 390-399, 1970.
46. Said TM, Agarwal A, Sharma RK, Mascha E, Sikka SC, and Thomas AJ, Jr. Human sperm superoxide anion generation and correlation with semen quality in patients with male infertility. Fertil Steril 82: 871-877, 2004.
47. Schaaf B, Wieghorst A, Aries SP, Dalhoff K, and Braun J. Neutrophil inflammation and activation in bronchiectasis: comparison with pneumonia and idiopathic pulmonary fibrosis. Respiration 67: 52-59, 2000.
48. Scott BC, Aruoma OI, Evans PJ, O'Neill C, Van der Vliet A, Cross CE, Tritschler H, and Halliwell B. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic Res 20: 119-133, 1994.
49. Souza HP, Laurindo FR, Ziegelstein RC, Berlowitz CO, and Zweier JL. Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. Am J Physiol Heart Circ Physiol 280: H658-667, 2001.
50. Stolarek R, Bialasiewicz P, and Nowak D. N-acetylcysteine effect on the luminol-dependent chemiluminescence pattern of reactive oxygen species generation by human polymorphonuclear leukocytes. Pulm Pharmacol Ther 15: 385-392, 2002.
51. Strausz J, Muller - Quernheim J, Steppling H, and Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 141: 124-128, 1990.
52. Suga M, Iyonaga K, Okamoto T, Gushima Y, Miyakawa H, Akaike T, and Ando M. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 162: 1949-1956, 2000.
53. Suzuki YJ, Tsuchiya M, and Packer L. Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radic Res Commun 18: 115-122, 1993.
54. Suzuki YJ, Tsuchiya M, and Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Commun 15: 255-263, 1991.
55. Teichert J, Hermann R, Ruus P, and Preiss R. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J Clin Pharmacol 43: 1257-1267, 2003.
56. Teichert J and Preiss R. HPLC-methods for determination of lipoic acid and its reduced form in human plasma. Int J Clin Pharmacol Ther Toxicol 30: 511-512, 1992.
57. Tian WN, Braunstein LD, Pang J, Stuhlmeier KM, Xi QC, Tian X, and Stanton RC. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem 273: 10609-10617, 1998.
58. Xaubet A, Agusti C, Luburich P, Barbera JA, Carrion M, Ayuso MC, Roca J, and Rodriguez - Roisin R. Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis. Respir Med 92: 338-344, 1998.
59. Zhang Y, Lee TC, Guillemin B, Yu MC, and Rom WN. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 150: 4188-4196, 1993.